Page last updated: 2024-12-11

pyruvatoxime

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pyruvatoxime: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6419427
CHEMBL ID4091867
SCHEMBL ID8157700
SCHEMBL ID23829697
MeSH IDM0043924

Synonyms (13)

Synonym
2-oximinopropanoic acid
2211-14-5
pyruvatoxime
(2e)-2-hydroxyiminopropanoic acid
AKOS006374332
propanoic acid, 2-(hydroxyimino)-
SCHEMBL8157700
(2e)-2-(hydroxyimino)propanoic acid
2-oximinopropanoate
kg7 ,
CHEMBL4091867
2-(hydroxyimino)-propanoic acid
SCHEMBL23829697
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1471796Reactivation of cyclosarin inhibited human erythrocyte AChE assessed as residual activity at 10 to 1000 uM using acetylthiocholine iodide as substrate preincubated for 2 to 120 mins followed by substrate addition measured for 3 mins by Ellman's method2017Journal of medicinal chemistry, 11-22, Volume: 60, Issue:22
Application of the Ugi Multicomponent Reaction in the Synthesis of Reactivators of Nerve Agent Inhibited Acetylcholinesterase.
AID1471798Reactivation of tabun inhibited human erythrocyte AChE assessed as residual activity at 10 to 1000 uM using acetylthiocholine iodide as substrate preincubated for 2 to 120 mins followed by substrate addition measured for 3 mins by Ellman's method2017Journal of medicinal chemistry, 11-22, Volume: 60, Issue:22
Application of the Ugi Multicomponent Reaction in the Synthesis of Reactivators of Nerve Agent Inhibited Acetylcholinesterase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (57.14)18.7374
1990's2 (14.29)18.2507
2000's0 (0.00)29.6817
2010's2 (14.29)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]